Carlyle Takes Majority in Knack, EqualizeRCM

Carlyle announced acquisition of a majority stake in U.S. healthcare RCM firms Knack RCM and EqualizeRCM, creating an AI-native global platform.
The deal, financed through Carlyle Asia Partners VI and Growth II funds, leaves founders Rajiv Sharma and Nagi Rao reinvesting proceeds.
Platform leverages Knack’s delivery and Workmate engine with Equalize’s AI tools like Bill Smart, targeting DME, anesthesia, eye care and rural hospitals.
Carlyle, managing $477 bn AUM, aims to scale the RCM platform and pursue further acquisitions in the fragmented healthcare revenue cycle market.